“Pill Esophagitis” — The Case of Alendronate
- 3 October 1996
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 335 (14) , 1058-1059
- https://doi.org/10.1056/nejm199610033351412
Abstract
Esophageal mucosal injury from the noxious effect of gastric contents refluxing up the esophagus is a common condition. Much less common is esophagitis from injurious agents passing down the esophagus, seen in its most dramatic form after the ingestion (usually accidental) of caustic alkali.1 The potential for medications, such as quinidine, potassium, and tetracycline derivatives, to cause esophagitis or discrete ulcers has recently been recognized.2 This effect usually results from prolonged contact of the medication with the esophageal mucosa and the ability of the drug to alter the local conditions, such as tetracycline's production of an acidic pH. It is . . .Keywords
This publication has 5 references indexed in Scilit:
- Esophagitis and AlendronateNew England Journal of Medicine, 1996
- Esophagitis Associated with the Use of AlendronateNew England Journal of Medicine, 1996
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Prevention of stricture formation after endoscopic sclerotherapy of esophageal varicesGastrointestinal Endoscopy, 1989
- THE PATHOLOGY OF EXPERIMENTALLY PRODUCED LYE BURNS AND STRICTURES OF THE ESOPHAGUSJournal of Thoracic Surgery, 1951